Mar 22 | Sep 21 | Mar 21 | Sep 20 | Mar 20 | |
---|---|---|---|---|---|
Income Statement | - | ||||
Total Revenue | - | - | - | - | - |
Gross Profit | - | - | - | - | - |
EBIT | - | - | - | - | - |
EBITDA | - | - | - | - | - |
Net Income Common Stockholders | - | - | - | - | - |
Balance Sheet | - | ||||
Cash, Cash Equivalents and Short-Term Investments | £ 12.50M | £ 32.49M | £ 74.81M | £ 28.09M | £ 76.66M |
Total Assets | £ 856.20M | £ 846.19M | £ 880.08M | £ 852.42M | £ 948.67M |
Total Debt | £ 58.80M | £ 61.69M | £ 115.71M | £ 70.14M | £ 142.22M |
Net Debt | £ 46.30M | £ 29.19M | £ 40.90M | £ 42.05M | £ 65.56M |
Total Liabilities | £ 355.50M | £ 351.12M | £ 386.03M | £ 335.05M | £ 407.91M |
Stockholders Equity | £ 500.70M | £ 495.07M | £ 494.05M | £ 517.38M | £ 539.79M |
Cash Flow | - | ||||
Free Cash Flow | - | - | - | - | - |
Operating Cash Flow | - | - | - | - | - |
Investing Cash Flow | - | - | - | - | - |
Financing Cash Flow | - | - | - | - | - |